Monica A. Slavin

Monica A. Slavin

Department of Infectious Diseases, Peter MacCallum Cancer Centre

Affiliated withPeter MacCallum Cancer Centre

Research Area

Biography

Monica A. Slavin has not added Biography.
If you are Monica A. Slavin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Whole Genome Sequencing of <em>Candida glabrata</em> for Detection of Markers of Antifungal Drug Resistance
Publication title

Cited by 22

2017

Other Publications

Article
Year
Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.

British journal of haematology| PubMed ID: 16371014

2006
2006
2007
2007
2007
2008
2009
2009
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.

The Journal of antimicrobial chemotherapy| PubMed ID: 20202987

2010
2010
Fluoroquinolone prophylaxis: a word of caution.

Leukemia & lymphoma| PubMed ID: 21067448

2011
Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.

Expert review of anti-infective therapy| PubMed ID: 21504403

2011
Anaerobes: not to be forgotten in neutropenic fever.

Leukemia & lymphoma| PubMed ID: 21534876

2011
2012
2012
A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment.

Australian health review : a publication of the Australian Hospital Association| PubMed ID: 22126955

2011
Staphylococcus aureus meningitis: barriers to treatment.

Leukemia & lymphoma| PubMed ID: 22360718

2012
Complications of sepsis: the role of risk prediction rules, biomarkers and host genetics.

Expert review of anti-infective therapy| PubMed ID: 22943396

2012
2013
Fluoroquinolone prophylaxis: worth the cost?

Leukemia & lymphoma| PubMed ID: 23035818

2013
2013
2013
2014
2015
2014
2014
2015
2014
2015
2015
2014
Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer| PubMed ID: 25487843

2015
2015
The impact of antimicrobial allergy labels on antimicrobial usage in cancer patients.

Antimicrobial resistance and infection control| PubMed ID: 26034582

2015
2015
2015
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 26113653

2015
2015
2015
2016
Isavuconazole: a role for the newest broad-spectrum triazole.

Lancet (London, England)| PubMed ID: 26684608

2016
2016
2016
Invasive fungal infections in ALL: a new 'growth' area.

Leukemia & lymphoma| PubMed ID: 27124301

2016
2016
2016
2016
The epidemiology of Clostridium difficile infection in patients with cancer.

Expert review of anti-infective therapy| PubMed ID: 27606976

2016
2016
2017
2016
Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer| PubMed ID: 28155020

2017
2017
Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer| PubMed ID: 28353037

2017
2017
2017
Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America| PubMed ID: 28520865

2017
2017
2017
2017
The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

The journal of allergy and clinical immunology. In practice| PubMed ID: 28843343

2017
External Validation of Six Pediatric Fever and Neutropenia Clinical Decision Rules.

The Pediatric infectious disease journal| PubMed ID: 28877157

2017
Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer| PubMed ID: 29018966

2017
2017
2017
2017
2017